Author Archive

IfPA Offers the Physician’s Perspective on Oncology Value Models

What is good value in terms of cancer treatment?  The question, amid rising cancer care costs, has prompted a surge of oncology value models in

Read More

***PRESS RELEASE*** South Carolina Health Plans Reject Nearly Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

***PRESS RELEASE*** Ohio Health Plans Reject Nearly Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

Summit on Biologics and Biosimilars Tackles Choice, Switching & Patient Access

Physicians and patients are no longer asking if a biological medicine is the best choice, but – more likely – which biological medicine is the

Read More

***MEDIA ADVISORY*** Thursday Summit on Biologics & Biosimilars Convenes Physicians, Advocates and Officials to Discuss Policy Issues

Summit will explore policies impacting patient access to biologic and biosimilar medications  WASHINGTON – Tomorrow the Institute for Patient Access and Biologics Prescribers Collaborative, a project

Read More

***VIDEO PRESS RELEASE*** AfPA Releases New Video “The Interchangeability Promise”

Video released ahead of 2nd Annual National Policy and Advocacy Summit on Biologics and Biosimilars  WASHINGTON – Today the Alliance for Patient Access released a

Read More

***PRESS RELEASE*** Michigan Health Plans Reject Nearly Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

New AfPA Video Examines “The Interchangeability Promise”

First came biologics, then biosimilars.  And soon, explains a newly released video from The Alliance for Patient Access, patients can expect interchangeable biosimilars.  According to

Read More

***PRESS RELEASE*** Kentucky Health Plans Reject Nearly Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

How to Achieve Hepatitis Elimination

Eliminating hepatitis B and C can be done, experts agree. And this week, a new report from the National Academies of Sciences, Engineering, and Medicine

Read More
Back to Top